Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regre... TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. Mehr anzeigen
TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial PR Newswire BOSTON, Jan. 14, 2025 Follows Safety Review Committee (SRC) approval...
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements PR Newswire BOSTON, Jan. 7, 2025 TransCode shares to remain listed on Nasdaq BOSTON, Jan...
TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial PR Newswire BOSTON, Dec...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -1.42857142857 | 3.5 | 3.5 | 2.9 | 98037 | 3.31969132 | CS |
| 4 | -0.17 | -4.69613259669 | 3.62 | 4 | 2.66 | 105275 | 3.45722847 | CS |
| 12 | -16.02 | -82.280431433 | 19.47 | 19.47 | 2.66 | 319592 | 11.17028355 | CS |
| 26 | -23.907 | -87.3889680886 | 27.357 | 27.72 | 2.66 | 1278541 | 13.55338343 | CS |
| 52 | -23.28 | -87.0931537598 | 26.73 | 66.33 | 2.66 | 1096813 | 20.98788248 | CS |
| 156 | -55436.55 | -99.9937770563 | 55440 | 81312 | 2.66 | 1508835 | 6761.34785308 | CS |
| 260 | -158396.55 | -99.9978219697 | 158400 | 184800 | 2.66 | 1618828 | 27939.0751607 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
